Ident. | Authors (with country if any) | Title |
---|
000176 (2015) |
Michael Samuel [Royaume-Uni] ; Maria Rodriguez-Oroz ; Angelo Antonini ; Jonathan M. Brotchie ; Kallol Ray Chaudhuri ; Richard G. Brown ; Wendy R. Galpern ; Melissa J. Nirenberg ; Michael S. Okun ; Anthony E. Lang | Management of impulse control disorders in Parkinson's disease: Controversies and future approaches. |
000190 (2015) |
T Celeste Napier [États-Unis] ; Jean-Christophe Corvol ; Anthony A. Grace ; Jamie D. Roitman ; James Rowe ; Valerie Voon ; Antonio P. Strafella | Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease. |
000295 (2015) |
Daniel Weintraub [États-Unis] ; Anthony S. David ; Andrew H. Evans ; Jon E. Grant ; Mark Stacy | Clinical spectrum of impulse control disorders in Parkinson's disease. |
000453 (2014) |
Robert A. Hauser [États-Unis] ; Dee Silver ; Azhar Choudhry ; Eli Eyal ; Stuart Isaacson | Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's disease. |
000473 (2014) |
Mathieu Favier [France] ; Theo Duran ; Carole Carcenac ; Guillaume Drui ; Marc Savasta ; Sebastien Carnicella | Pramipexole reverses Parkinson's disease-related motivational deficits in rats. |
000718 (2013) |
Mario Mastrangelo ; Caterina Caputi ; Serena Galosi ; Maria Teresa Giannini ; Vincenzo Leuzzi | Transdermal rotigotine in the treatment of aromatic L-amino acid decarboxylase deficiency. |
000787 (2013) |
Karen L. Eskow Jaunarajs [États-Unis] ; David G. Standaert ; Tacey X. Viegas ; Michael D. Bentley ; Zhihao Fang ; Bekir Dizman ; Kunsang Yoon ; Rebecca Weimer ; Paula Ravenscroft ; Tom H. Johnston ; Michael P. Hill ; Jonathan M. Brotchie ; Randall W. Moreadith | Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefit. |
000796 (2013) |
Michele Poletti ; Ubaldo Bonuccelli | Reply: dopamine agonists and delusional jealousy in Parkinson's disease: a cross-sectional prevalence study. |
000A22 (2013) |
Maria Stamelou ; Christos Christodoulou ; Leonidas Stefanis | Dopamine agonists and delusional jealousy in Parkinson's disease: a cross-sectional prevalence study. |
000A37 (2013) |
Eugenia Storti ; Francesca Cortese ; Roberto Di Fabio ; Chiara Fiorillo ; Alberto Pierallini ; Alessandra Tessa ; Annamaria Valleriani ; Francesco Pierelli ; Filippo M. Santorelli ; Carlo Casali | De novo FTL mutation: a clinical, neuroimaging, and molecular study. |
000A78 (2013) |
David J. Graham [États-Unis] ; James R. Williams ; Ya-Hui Hsueh ; Katlyn Calia ; Mark Levenson ; Simone P. Pinheiro ; Thomas E. Macurdy ; David Shih ; Chris Worrall ; Jeffrey A. Kelman | Cardiovascular and mortality risks in Parkinson's disease patients treated with entacapone. |
000C68 (2012) |
Michael S. Okun | Parkinson's disease patients cannot get their dopamine replacement: the 8-Sinemet limit. |
000E09 (2012) |
Michele Poletti [Italie] ; Giulio Perugi ; Chiara Logi ; Anna Romano ; Paolo Del Dotto ; Roberto Ceravolo ; Giuseppe Rossi ; Pasquale Pepe ; Liliana Dell'Osso ; Ubaldo Bonuccelli | Dopamine agonists and delusional jealousy in Parkinson's disease: a cross-sectional prevalence study. |
000F14 (2012) |
Roger Kurlan [États-Unis] ; Giovanna Crespi ; Barbara Coffey ; Kirsten Mueller-Vahl ; Stephen Koval ; Glen Wunderlich | A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome. |
001157 (2012) |
Donald L. Bliwise [États-Unis] ; Lynn Marie Trotti [États-Unis] ; Anthony G. Wilson [États-Unis] ; Sophia A. Greer [États-Unis] ; Cathy Wood-Siverio [États-Unis] ; Jorge J. Juncos [États-Unis] ; Stewart A. Factor [États-Unis] ; Alan Freeman [États-Unis] ; David B. Rye [États-Unis] | Daytime Alertness in Parkinson's Disease: Potentially Dose-Dependent, Divergent Effects by Drug Class |
001397 (2011) |
Claudia Trenkwalder [Allemagne] ; Bryan Kies [Afrique du Sud] ; Monika Rudzinska [Pologne] ; Jennifer Fine [Afrique du Sud] ; Janos Nikl [Hongrie] ; Krystyna Honczarenko [Pologne] ; Peter Dioszeghy [Hongrie] ; Dennis Hill [États-Unis] ; Tim Anderson [Nouvelle-Zélande] ; Vilho Myllyla [Finlande] ; Jan Kassubek [Allemagne] ; Malcolm Steiger [Royaume-Uni] ; Marco Zucconi [Italie] ; Eduardo Tolosa [Espagne] ; Werner Poewe [Autriche] ; Erwin Surmann [Allemagne] ; John Whitesides [États-Unis] ; Babak Boroojerdi [Allemagne] ; Kallol Ray Chaudhuri [Royaume-Uni] ; the RECOVER Study Group [Allemagne, Afrique du Sud, Pologne, Hongrie, États-Unis, Nouvelle-Zélande, Finlande, Royaume-Uni, Italie, Espagne, Autriche] | Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER) |
001608 (2011) |
Maria Milenkova [Allemagne, Bulgarie] ; Bahram Mohammadi [Allemagne] ; Katja Kollewe [Allemagne] ; Christoph Schrader [Allemagne] ; Anja Fellbrich [Allemagne] ; Matthias Wittfoth [Allemagne] ; Reinhard Dengler [Allemagne] ; Thomas F. Münte [Allemagne] | Intertemporal choice in Parkinson's disease |
001A22 (2010) |
Wayne A. Hening [États-Unis] ; Richard P. Allen [États-Unis] ; William G. Ondo [États-Unis] ; Arthur S. Walters [États-Unis] ; John W. Winkelman [États-Unis] ; Philip Becker [États-Unis] ; Richard Bogan [États-Unis] ; June M. Fry [États-Unis] ; David B. Kudrow [États-Unis] ; Kurt W. Lesh [États-Unis] ; Andreas Fichtner [Allemagne] ; Erwin Schollmayer [Allemagne] | Rotigotine improves restless legs syndrome: A 6‐month randomized, double‐blind, placebo‐controlled trial in the United States |
001A23 (2010) |
M. K. Karvonen [Finlande] ; V. Kaasinen [Finlande] ; M. Korja [Finlande] ; R. J. Marttila [Finlande] | Ropinirole diminishes myoclonus and improves writing and postural balance in an ULD patient |
001C73 (2010) |
Xin Liu [République populaire de Chine] ; Shu-Shan Zhang [République populaire de Chine] ; Deng-Fu Fang [République populaire de Chine] ; Ming-Yi Ma [République populaire de Chine] ; Xiao-Yan Guo [République populaire de Chine] ; Yuan Yang [République populaire de Chine] ; Hui-Fang Shang [République populaire de Chine] | GCH1 mutation and clinical study of Chinese patients with dopa‐responsive dystonia |
001D25 (2010) |
Bonnie P. Hersh [États-Unis] ; Nancy L. Earl [États-Unis] ; Robert A. Hauser [États-Unis] ; Mark Stacy [États-Unis] | Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations |